Literature DB >> 14534544

Biallelic inactivation of the RIZ1 gene in human gastric cancer.

Yutaka Tokumaru1, Shuji Nomoto, Carmen Jerónimo, Rui Henrique, Susan Harden, Barry Trink, David Sidransky.   

Abstract

The distal short arm of chromosome 1 is commonly deleted in a variety of human neoplasms including gastrointestinal cancer. Genetic alterations of the retinoblastoma protein-interacting zing-finger gene (RIZ)1 including loss of heterozygosity (LOH) at 1p36, frameshift mutations, and promoter hypermethylation were reported previously in several cancers. In this study, we evaluated RIZ1 in 30 primary gastric cancers and found frameshift mutations in two cases (6.7%). Moreover, using real-time quantitative methylation-specific PCR, methylation of the RIZ1 promoter was detected in 11 (37%) cases. In all 11 cases with methylation, inactivation of the second allele occurred through frameshift mutation, LOH or promoter methylation. Our results suggest that RIZ1 is a specific target of inactivation in human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534544     DOI: 10.1038/sj.onc.1206403

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

2.  Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.

Authors:  Shang-Wen Dong; Peng Zhang; Yi-Mei Liu; Yuan-Tao Cui; Shuo Wang; Shao-Jie Liang; Zhun He; Pei Sun; Yuan-Guo Wang
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

3.  Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation.

Authors:  Shang-Wen Dong; Dong Li; Cong Xu; Pei Sun; Yuan-Guo Wang; Peng Zhang
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma.

Authors:  Prasong Khaenam; Patcharee Jearanaikoon; Chawalit Pairojkul; Vajarabhongsa Bhudhisawasdi; Temduang Limpaiboon
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

Review 5.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

6.  Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.

Authors:  Jingcui Yu; Peng Liu; Xiaobo Cui; Yu Sui; Guohua Ji; Rongwei Guan; Donglin Sun; Wei Ji; Fangli Liu; An Liu; Yuzhen Zhao; Yang Yu; Yan Jin; Jing Bai; Jingshu Geng; Yingwei Xue; Jiping Qi; Ki-Young Lee; Songbin Fu
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

Review 7.  Pathogenetic mechanisms in gastric cancer.

Authors:  Jing Shi; Yi-Ping Qu; Peng Hou
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Authors:  Yu-Wei Cheng; Hanna Pincas; Manny D Bacolod; Gunter Schemmann; Sarah F Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A Notterman; Jurg Ott; Philip Paty; Francis Barany
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.

Authors:  Yu Cheng; Jin Woo Kim; Wennuan Liu; Thomas A Dunn; Jun Luo; Matthew J Loza; Seong-Tae Kim; Siqun Lilly Zheng; Jianfeng Xu; William B Isaacs; Bao-Li Chang
Journal:  Prostate       Date:  2009-02-15       Impact factor: 4.104

10.  Genetic and epigenetic inactivation of LPL gene in human prostate cancer.

Authors:  Jin Woo Kim; Yu Cheng; Wennuan Liu; Tao Li; Srinivasan Yegnasubramanian; Siqun L Zheng; Jianfeng Xu; William B Isaacs; Bao-Li Chang
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.